Pinnacle Treatment Centers Expands Medication Options for Recovery
Pinnacle Treatment Centers is leading the charge in the battle against Substance Use Disorder (SUD) by introducing three significant medication options across its New Jersey facilities. These new additions—Sublocade, Brixadi, and Vivitrol—are designed to provide effective support to those looking to reclaim their lives from opioid addiction.
Understanding the New Treatment Options
Sublocade is an innovative injectable medication that offers a once-monthly treatment essential for assisting individuals in overcoming cravings and withdrawal symptoms associated with opioid withdrawal. This medication provides stabilized medication levels, allowing patients to focus on their recovery without the frequent disruptions that oral medications can cause.
The Mechanics of Sublocade
This medication primarily uses buprenorphine, which is known for its ability to alleviate withdrawal symptoms. It’s tailored especially for patients transitioning from oral buprenorphine medications like Suboxone, providing a supportive pathway toward recovery that is both practical and effective.
The Advantages of Brixadi
Brixadi offers a newer approach with both weekly and monthly injectable options. Its design aims to give healthcare providers the flexibility to better align treatment with each patient’s unique recovery journey. This flexibility can be critical during various stages of recovery, ensuring comprehensive care tailored to individual needs.
How Brixadi Works
Like Sublocade, Brixadi functions by partially activating opioid receptors to help manage cravings and behavioral symptoms. This empowering choice allows clinicians to enhance the treatment experience, making it as personalized as possible for those in need.
Vivitrol: A Key Player in Relapse Prevention
Vivitrol is another once-monthly injectable option that operates differently by blocking opioid receptors, thereby minimizing the chances of relapse. This medication targets both opioid and alcohol use disorders, which can be beneficial for patients with dual diagnoses. By eliminating the euphoric effects associated with opioids, it plays a crucial role in aiding long-term recovery.
Initial Considerations for Vivitrol
Before starting treatment with Vivitrol, patients must undergo withdrawal management to reduce the risk of potential withdrawal symptoms. This preparatory step is vital to ensure that individuals are ready and able to start their recovery process safely and effectively.
Commitment to Comprehensive Care
Dr. Daniel Brown, the Chief Medical Officer at Pinnacle Treatment Centers, emphasizes the organization's commitment to providing effective treatment options. "At Pinnacle Treatment Centers, we understand how important it is to provide effective, lasting treatment options for people struggling with Opioid Use Disorder. By offering medications like Sublocade, Brixadi, and Vivitrol in our New Jersey facilities, we're broadening access to proven, evidence-based care that supports sustained recovery in meaningful ways," he states.
Collaboration for Recovery
Pinnacle Treatment Centers encourages community partners to unite in their mission to assist individuals on their recovery journeys. The facility recognizes the need for a network of support, highlighting that anyone aware of a patient who could benefit from these innovative treatments should reach out.
Contact Information
If you know someone who could benefit from these medications, Pinnacle’s 24/7 Access Center is always available. The center can be reached at 85-PINNACLE (857-466-2253) for more information or to refer a patient. Alternatively, you can find detailed information on their website.
About Pinnacle Treatment Centers
Pinnacle Treatment Centers stands out as a provider of essential substance abuse treatment services, prioritizing accessible and affordable care. Their offering encompasses various services, from withdrawal management and outpatient programs to sober living arrangements and Medications for Opioid Use Disorder (MOUD). Their evidence-based approach is foundational in creating personalized care plans that respond to the unique challenges faced by each individual seeking recovery.
Frequently Asked Questions
What medications are now offered by Pinnacle Treatment Centers?
Pinnacle Treatment Centers now offers Sublocade, Brixadi, and Vivitrol as part of their opioid treatment options.
How does Sublocade help patients?
Sublocade provides a monthly injectable form of medication that stabilizes patients by reducing cravings and withdrawal symptoms associated with opioid use.
What is the benefit of using Brixadi?
Brixadi gives clinicians the flexibility of weekly and monthly injections, helping to tailor treatments according to patients' needs.
How does Vivitrol prevent relapse?
Vivitrol works by blocking opioid receptors, removing the euphoric effects of opioids and preventing relapse into addiction.
How can community members refer patients to Pinnacle Treatment Centers?
Community members can refer patients by contacting Pinnacle's 24/7 Access Center at 85-PINNACLE (857-466-2253) or visiting their website for more information.
